Print this page    •   Back to Web version of article

New FDA Hepatitis List Serve

March 12, 2009

The Food and Drug Administration is launching a new hepatitis list serve. This new e-mail list will provide updates on safety and regulatory issues related to hepatitis B and C products as they become available (rather than on a regularly scheduled basis).

The e-mail list is intended to give patients, industry, academia, government agencies, and other interested parties, one source for FDA hepatitis B and C related information on a variety of topics, including:

You can subscribe to the new hepatitis e-mail list by simply clicking the link below:

or pasting it into your browser.

You will get an e-mail acknowledgment shortly after signing up.

Richard Klein
Office of Special Health Issues
Food and Drug Administration

Kimberly Struble
Division of Antiviral Drug Products
Food and Drug Administration

This article was provided by U.S. Food and Drug Administration. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.